Aiping Young, MD, PhD

Dr. Young brings 30 years of experience in the biotechnology sector as a co-founder, senior executive, and investor.

Dr. Young co-founded GeneSense Technology and successfully transformed it into a robust public company, leading to a merger with Lorus Therapeutics and a subsequent buyout by Aptose Biosciences. Throughout her career, she has held key positions, including VP of R&D, Chief Technology Officer, Chief Operating Officer, and President & CEO. Dr. Young has raised over $100M in private equity for both small and large biotechs. She has also been involved in several private startups from the earliest stages.

Dr. Young earned her MD from Jiangxi Chinese Medical University in China and her PhD in Pharmacology from Toyama Medical & Pharmaceutical University in Japan.